[Whitepaper] Sensors Provide Useful RWD in Clinical Trials

May 24, 2021

The use of sensors and wearables in clinical trials is rapidly increasing, a trend that has been accelerated by the COVID-19 pandemic. A new whitepaper discusses how the clinical trial landscape is incorporating sensors into study design and highlights common challenges associated with sensors.

“Sensors are transforming clinical trials by providing a 24/7 stream of objective insights into the health of patients. Sponsors, sites and most importantly patients all benefit from sensors, and use of the devices was on the rise even before COVID-19 turbocharged adoption. Yet, the nascent, fast-moving sensor sector poses challenges. Sponsors that navigate those challenges will be richly rewarded with clinical trials that generate new insights at record speeds.” Read more here.

(Source: Fierce Pharma, 2021)

Share This Story!